Blackston Financial Advisory Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$501K Buy
1,989
+14
+0.7% +$3.01K 0.28% 50
2026
Q1
$430K Sell
1,975
-271
-12% -$60.1K 0.27% 51
2025
Q4
$513K Sell
2,246
-71
-3% -$16.2K 0.31% 47
2025
Q3
$537K Sell
2,317
-107
-4% -$21.8K 0.32% 48
2025
Q2
$450K Buy
2,424
+110
+5% +$20.4K 0.28% 53
2025
Q1
$485K Sell
2,314
-2,514
-52% -$489K 0.33% 45
2024
Q4
$858K Buy
4,828
+117
+2% +$21.5K 0.43% 37
2024
Q3
$931K Buy
4,711
+436
+10% +$81.4K 0.48% 29
2024
Q2
$733K Buy
4,275
+3,138
+276% +$520K 0.41% 28
2024
Q1
$207K Sell
1,137
-2,335
-67% -$402K 0.14% 60
2023
Q4
$538K Buy
3,472
+43
+1% +$6.27K 0.34% 42
2023
Q3
$511K Buy
3,429
+219
+7% +$32.1K 0.36% 43
2023
Q2
$432K Sell
3,210
-339
-10% -$49.7K 0.31% 49
2023
Q1
$566K Sell
3,549
-164
-4% -$25.1K 0.42% 39
2022
Q4
$600K Sell
3,713
-88
-2% -$13.5K 0.44% 38
2022
Q3
$557K Buy
3,801
+287
+8% +$41.2K 0.39% 43
2022
Q2
$534K Buy
3,514
+994
+39% +$152K 0.35% 39
2022
Q1
$272K Sell
2,520
-379
-13% -$55.1K 0.18% 65
2021
Q4
$393K Buy
+2,899
New +$342K 0.23% 51

Other funds holding ABBV

Blackston Financial Advisory Group's ABBV Position: Q2 2026 in Review

Blackston Financial Advisory Group increased its AbbVie (ABBV) stake by 0.71% in Q2 2026, buying an estimated $3.01K and bringing the position to 1,989 shares worth $501K. The position accounts for 0.28% of the portfolio, ranked #50.

Blackston Financial Advisory Group first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $931K in Q3 2024. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Blackston Financial Advisory Group held 1,989 shares of AbbVie worth $501K as of Q2 2026.
  • Blackston Financial Advisory Group bought 14 AbbVie shares in Q2 2026, an estimated $3.01K.
  • AbbVie made up 0.28% of Blackston Financial Advisory Group's portfolio in Q2 2026, its #50 holding.
  • Blackston Financial Advisory Group first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • Blackston Financial Advisory Group's AbbVie position peaked at $931K in Q3 2024.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Blackston Financial Advisory Group's 13F filing for Q2 2026, filed 14 Aug 2026.